Supporters
Partners
Panic Disorders
A panic attack is an episode of intense fear or psychological distress which suddenly appears and symptoms include trembling, shortness of breath, heart palpitations, sweating, nausea, dizziness, hyperventilation and sensations of choking. Repeated attacks may be a sign of a panic disorder and are usually associated with other anxiety problems. It is estimated that up to 10 percent of people in the U.S. will experience a panic disorder at some point in their lives.
| Company | Product | Phase | |
| Watson Pharmaceuticals Inc | Clonazepam | M | Panic Disorder |
| Alexza Pharmaceuticals Inc | AZ002 | II | Panic Disorder |
Parkinson Disease
Parkinson's disease is a disorder that affects nerve cells, or neurons, in a part of the brain that controls muscle movement. In Parkinson's, neurons that make a chemical called dopamine die or do not work properly. Dopamine normally sends signals that help coordinate a person’s movements. No one knows what damages these cells. This disease affects 1.5 million in the U.S. and may progress for years.
| Company | Product | Phase | |
| Watson Pharmaceuticals Inc | Eldepryl | M | Parkinson Disease |
| Watson Pharmaceuticals Inc | Selegiline | M | Parkinson Disease |
| Valeant Pharmaceuticals International | Selgres | M | Parkinson Disease |
| Valeant Pharmaceuticals International | Symmetrel | M | Parkinson Disease |
| Valeant Pharmaceuticals International | Tasmar | M | Parkinson Disease |
| Watson Pharmaceuticals Inc | Trihexyphenidyl hydrochloride | M | Parkinson Disease |
| Valeant Pharmaceuticals International | Zelapar | M | Parkinson Disease |
| Adamas Pharmaceuticals, Inc. | ADS5101 | III | Parkinson Disease |
| Impax Laboratories Inc | Carbidopa, Levodopa ER | III | Parkinson Disease |
| Impax Laboratories Inc. | IPX066 | III | Parkinson Disease |
| Avicena Group Inc | PD02 | III | Parkinson Disease |
| ACADIA Pharmaceuticals Inc | Pimavanserin | III | Parkinson Disease |
| Ceregene Inc | CERE120 | II | Parkinson Disease |
| Titan Pharmaceuticals Inc | Spheramine | II | Parkinson Disease |
| Xenoport Inc | XP21279 with Lodosyn and Sinemet | II | Parkinson Disease |
Restless Leg Syndrome (RLS)
Restless legs syndrome (RLS) is a disorder that causes a strong urge to move your legs. This urge to move often occurs with strange and unpleasant feelings in your legs. Moving your legs relieves the urge and the unpleasant feelings. People who have RLS describe the unpleasant feelings as creeping, crawling, pulling, itching, tingling, burning, aching, or electric shocks. Sometimes, the feelings also occur in the arms. The urge to move and unpleasant feelings occur when you’re resting and inactive. They tend to be worse in the evening and at night and are temporarily relieved in the morning. Restless legs syndrome (RLS) may affect as many as 12 million people in the United States.
| Company | Product | Phase | |
| Xenoport Inc | Solzira | PA | Restless Leg Syndrome |
| Jazz Pharmaceuticals | JZP7 | II | Restless Leg Syndrome |
